The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Risk scores at coronary revascularisation Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by